TV News LIES

Sunday, Apr 22nd

Last update05:20:13 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


200 million eggs recalled over salmonella fears

200 million eggs recalled for fear of salmonellaMore than 200 million eggs are being recalled over fears of salmonella. Rose Acre Farms of Seymour,...

Blood test can detect Alzheimer's years before symptoms

Bllod test can detect Alzheimer's years before onsetResearchers in Germany have developed a blood test for Alzheimer's that detects the disease several years...

Arizona House Passes Bill Requiring Women Seeking Abortions To Say Why

Arizona passes bill requiring women requesting abortions to answer why The Arizona state House of Representatives passed a bill that would require women seeking abortions to...

McKesson accused of skimming profit, harming patients

McKesson accused of mishandling cancer drugOmni Healthcare is suing wholesale drug distributor McKesson Corp. on behalf of the federal government and...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!